Hyperprolactinemia and hypogonadism in the human female

Area of Science:

• Endocrinology
• Reproductive Biology

Background:

• Prolactin is a key hormone for lactation and influences ovarian function.
• Hyperprolactinemia, both pathological and physiological (early puerperium), leads to hypogonadism.
• Amenorrhea is a more sensitive indicator of hyperprolactinemia than galactorrhea.

Purpose of the Study:

• To explore the mechanisms by which prolactin affects ovarian function.
• To discuss the treatment options for hyperprolactinemia.

Main Methods:

• Review of existing literature on prolactin's effects on the hypothalamic-pituitary-ovarian axis.
• Analysis of proposed mechanisms including hypothalamic neurotransmitter alterations, direct pituitary effects, and gonadal interference.

Main Results:

• Prolactin likely decreases Gonadotropin-Releasing Hormone (Gn-RH) via hypothalamic feedback.
• Direct effects of prolactin on gonadotrophs or gonadal function are also potential mechanisms.
• Bromocriptine is a highly effective treatment for hyperprolactinemia.

Conclusions:

• Hyperprolactinemia disrupts reproductive function through complex mechanisms.
• Bromocriptine is the preferred medical treatment.
• Surgical or radiological interventions are considered for significant pituitary tumors.